Embolx Launches K-Tip Design for the Sniper Balloon Occlusion Microcatheter Family


May 9, 2019—Embolx, Inc. announced the commercial launch of its Sniper K-tip balloon occlusion microcatheter in the United States and Europe. The Sniper K-tip is a 45º angled tip designed to enhance tracking and vessel access capabilities.

According to the company, this extension to the Sniper family of microcatheters offers physicians the ability to customize treatment with an array of different balloon microcatheter length and tip options. The Sniper microcatheters are available with two tip options, straight or K-tip, and in three lengths, 110, 130, and 150 cm. The K-tip offers improved control and torqueability through hard-to-navigate vessels to deliver targeted embolization treatment.

The Sniper microcatheter alters blood flow‐dynamics by controlling pressure to increase therapeutic agent delivery into target areas. It is currently used for the treatment of cancerous tumors in the liver and other organs, benign prostatic hyperplasia, and uterine fibroids.

Brian Kouri, MD, Associate Professor in Interventional Radiology at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, commented in the company's press release, “Sniper has changed the way I do both chemoembolization and radioembolization. With Sniper, I am able to infuse a higher volume of the embolic agent into a smaller, focused area. This allows me to treat tumors more aggressively with less impact on normal liver tissue."

Dr. Kouri continued, "My initial case experience with Sniper’s new K-tip design has been great in every respect. It allowed me to access some pretty small vessels quickly and navigate an over 180º vessel turn into the right gastric artery. The tip performance is impressive as it easily tracks inside vessels and torques on a one-to-one basis allowing the Sniper to make sharp vessel turns.”


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.